GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Total Current Liabilities

Nuformix (LSE:NFX) Total Current Liabilities : £0.19 Mil (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Nuformix's total current liabilities for the quarter that ended in Sep. 2022 was £0.19


Nuformix Total Current Liabilities Historical Data

The historical data trend for Nuformix's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Total Current Liabilities Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Total Current Liabilities
Get a 7-Day Free Trial 0.53 0.82 0.35 0.33 0.24

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.17 0.24 0.19 0.27

Nuformix Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Nuformix's Total Current Liabilities for the fiscal year that ended in Mar. 2022 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.02+0
+Other Current Liabilities+Current Deferred Liabilities
=0.218+0
=0.24

Nuformix's Total Current Liabilities for the quarter that ended in Sep. 2022 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.188+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Nuformix Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Nuformix's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix (LSE:NFX) Business Description

Industry
Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix (LSE:NFX) Headlines

From GuruFocus

Newfield's Production Plans: Everything You Need to Know

By Sarfaraz A. Khan Sarfaraz A. Khan 12-27-2013

4 Independent Oil Drillers To Acquire Today

By Vatalyst.com Vatalyst.com 03-09-2012

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 10,000 Shares

By GuruFocus Research GuruFocus Editor 12-29-2009